These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 35300444)

  • 1. Connection between the Plasma Level of Apelin and Diabetic Nephropathy in Type 2 Diabetic Patients. A Case Control Study.
    Helmy MY; Hamdy N; Ghaffar NAE
    Indian J Endocrinol Metab; 2021; 25(5):418-426. PubMed ID: 35300444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation between plasma Apelin level and peripheral neuropathy in Type 2 diabetic patients.
    Hosny SS; Nasr MS; Ibrahim RH; YousryHelal Z
    Diabetes Metab Syndr; 2019; 13(1):626-629. PubMed ID: 30641779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the relationship between serum apelin levels and vitamin D and mean platelet volume in diabetic patients.
    Kiskac M; Zorlu M; Cakirca M; Karatoprak C; Kesgin S; Büyükaydın B; Yavuz E; Ardic C; Camli AA; Cikrikcioglu MA
    Ann Endocrinol (Paris); 2014 Sep; 75(4):200-5. PubMed ID: 25156130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apelin: A potential novel serum biomarker for early detection of diabetic nephropathy in patients with type 2 diabetes.
    Demirpence M; Yilmaz H; Colak A; Pamuk BO; Karakoyun I; Basok B
    North Clin Istanb; 2019; 6(2):151-155. PubMed ID: 31297482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulating effect of atorvastatin on paraoxonase 1 activity in type 2 diabetic Egyptian patients with or without nephropathy.
    Abdin AA; Hassanien MA; Ibrahim EA; El-Noeman Sel-D
    J Diabetes Complications; 2010; 24(5):325-33. PubMed ID: 19553142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An evaluation of both serum Klotho/FGF-23 and apelin-13 for detection of diabetic nephropathy.
    Ozdemir N; Toraman A; Taneli F; Yurekli BS; Hekimsoy Z
    Hormones (Athens); 2023 Sep; 22(3):413-423. PubMed ID: 37458962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Apelin-13 levels in patients with diabetic nephropathy.
    İçen G; Dağlıoğlu G; Evran M
    Int Urol Nephrol; 2023 Feb; 55(2):345-353. PubMed ID: 35925488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of apelin‑13 and its negative correlation with TGF‑β1 in patients with diabetic kidney disease.
    Wang Q; Liu X; Zhai A; Xu H; Ma S; Liu Y
    Exp Ther Med; 2024 Mar; 27(3):110. PubMed ID: 38361517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apelin, Nitric Oxide and Vascular Affection in Adolescent Type 1 Diabetic Patients.
    Dayem SMAE; Battah AA; Bohy AEME; Yousef RN; Ahmed AM; Talaat AA
    Open Access Maced J Med Sci; 2017 Dec; 5(7):934-939. PubMed ID: 29362622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low serum apelin levels are associated with mild cognitive impairment in Type 2 diabetic patients.
    Jiang Y; Wang S; Liu X
    BMC Endocr Disord; 2022 May; 22(1):137. PubMed ID: 35610700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low plasma apelin levels in newly diagnosed type 2 diabetes mellitus.
    Erdem G; Dogru T; Tasci I; Sonmez A; Tapan S
    Exp Clin Endocrinol Diabetes; 2008 May; 116(5):289-92. PubMed ID: 18484561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic Accuracy of Serum Cystatin C for Early Recognition of Nephropathy in Type 2 Diabetes Mellitus.
    Sapkota S; Khatiwada S; Shrestha S; Baral N; Maskey R; Majhi S; Chandra L; Lamsal M
    Int J Nephrol; 2021; 2021():8884126. PubMed ID: 33996155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential value of serum Progranulin as a biomarker for the presence and severity of micro vascular complications among Egyptian patients with type 2 diabetes mellitus.
    Albeltagy ES; Hammour AE; Albeltagy SA
    J Diabetes Metab Disord; 2019 Jun; 18(1):217-228. PubMed ID: 31275893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Association of Vitamin K2 Level with the Glycaemic Status in Type 2 Diabetic Patients: A Case-Control Study.
    Helmy MY; Elsaid NH; Gwad MMA
    Indian J Endocrinol Metab; 2022; 26(1):87-92. PubMed ID: 35662764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical efficacies, underlying mechanisms and molecular targets of Chinese medicines for diabetic nephropathy treatment and management.
    Tang G; Li S; Zhang C; Chen H; Wang N; Feng Y
    Acta Pharm Sin B; 2021 Sep; 11(9):2749-2767. PubMed ID: 34589395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid Abnormalities in Type 2 Diabetes Mellitus Patients with Overt Nephropathy.
    Palazhy S; Viswanathan V
    Diabetes Metab J; 2017 Apr; 41(2):128-134. PubMed ID: 28447439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of Serum Apelin and Insulin Resistance in Type 2 Diabetes Mellitus Patients With or Without Obesity.
    Mund C; Kellellu CK; Rattan R; Mahapatra S; Lamare AA; Jena S
    Cureus; 2023 Aug; 15(8):e43401. PubMed ID: 37706122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Change and significance of urinary smad3 in type 2 diabetic nephropathy].
    Guo KF; Kou JX; Lu JX; Zhang L; Yu HY; Chen HB
    Zhonghua Yi Xue Za Zhi; 2013 Apr; 93(14):1067-71. PubMed ID: 23902838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma angiotensin II, renin activity and serum angiotensin-converting enzyme activity in non-insulin dependent diabetes mellitus patients with diabetic nephropathy.
    Nicola W; Sidhom G; El Khyat Z; Ibrahim S; Salah A; El Sayed A
    Endocr J; 2001 Feb; 48(1):25-31. PubMed ID: 11403100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Relationship between serum cystatin-C levels and vibrating perception threshold in patients with 
Type 2 diabetes mellitus].
    Yan P; Zhang Z; Xu Y; Wan Q; Ma H; He J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Jan; 41(1):58-64. PubMed ID: 26819426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.